Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1994 | 12-1993 | 12-1992 | 12-1991 | 12-1990 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | 2,668 | 4,073 | N/A | 87 |
| Inventories | N/A | 0 | 3 | N/A | 10 |
| Other current assets | 0 | 27 | 25 | 0 | 29 |
| TOTAL | $N/A | $2,695 | $4,100 | $N/A | $126 |
| Non-Current Assets | |||||
| PPE Net | N/A | 51 | 31 | N/A | 18 |
| Other Non-Current Assets | 0 | 80 | 4 | 0 | 24 |
| TOTAL | $N/A | $131 | $35 | $N/A | $42 |
| Total Assets | $N/A | $2,826 | $4,136 | $N/A | $167 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 89 | 60 | 0 | 10 |
| TOTAL | $N/A | $89 | $60 | $N/A | $10 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $N/A | $89 | $60 | $N/A | $10 |
| Shareholders' Equity | |||||
| Common Shares | N/A | 5,525 | 5,525 | N/A | 319 |
| Retained earnings | N/A | -2,949 | -1,610 | N/A | -256 |
| Other shareholders' equity | 0 | 67 | 67 | 0 | 0 |
| TOTAL | $N/A | $2,737 | $4,076 | $N/A | $158 |
| Total Liabilities And Equity | $0 | $2,826 | $4,136 | $0 | $167 |